Thought Leadership

Latest Report

ASH Preview 2023: Ones to Watch

The American Society of Hematology (ASH) Annual Meeting and Exposition is the last big clinical conference of the year. As we head into 2024, which areas are set to attract investment with their latest datasets, and which are in danger of falling flat?  ASH will see the latest data reveals on CAR-T products, multiple myeloma, leukaemia and…

Report library

ASCO 2023 Round Up

The Evaluate Vantage team are back from the 2023 ASCO Annual Meeting in Chicago, where we've been reporting on all the big data drops and breakthroughs in cancer…

Q1 2023 Round Up: And so it continues...

2022 was a rough year for much of the pharma sector, with limited M&A, IPO, and venture financing activity. With Q1 now over, are we expecting to see an improvement…

Quarter 1 Round up 2023 Infographic

Pharma has had a tough go of it over the past year, with limited M&A, IPO, and venture financing activity. As Q1 draws to a close, many are wondering if the sector is…

CROI 2023 article pack

Thanks to the forum it provides the Conference on Retroviruses and Opportunistic Infections (CROI) has helped to facilitate the accelerating progress in HIV and AIDS…

Pharma Drivers: Money for Nothing

This eBook analyses the routes biotech companies are taking to gain access to public markets. While Spacs had their moment in the sun, they are now widely perceived as a…